強生押注Isomorphic開展人工智能驅動的藥物搜尋J&J bets on Isomorphic for AI-powered drug hunt

動脈網

01/20

Alphabet-backed startup Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine.Alphabet支持的初創公司Isomorphic Labs已將另一家制藥公司加入到使用其基於人工智能的藥物...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2605145903"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2605145903\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2605145903?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-20 22:28","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2605145903","market":"us","top_or_hot":-1,"title":"強生押注Isomorphic開展人工智能驅動的藥物搜尋J&J bets on Isomorphic for AI-powered drug hunt","media":"動脈網","content":"<div>\n<p>Alphabet-backed startup Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine.Alphabet支持的初創公司Isomorphic Labs已將另一家制藥公司加入到使用其基於人工智能的藥物...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120222915a7310498&s=b\">網頁鏈接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>強生押注Isomorphic開展人工智能驅動的藥物搜尋J&J bets on Isomorphic for AI-powered drug hunt</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n強生押注Isomorphic開展人工智能驅動的藥物搜尋J&J bets on Isomorphic for AI-powered drug hunt\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">動脈網</strong><span class=\"h-time small\">2026-01-20 22:28</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>Alphabet-backed startup Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine.Alphabet支持的初創公司Isomorphic Labs已將另一家制藥公司加入到使用其基於人工智能的藥物...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120222915a7310498&s=b\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120222915a7310498&s=b\">動脈網</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1732799900.SGD","symbol_name":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120222915a7310498&s=b","article_id":"2605145903","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120222915a7310498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2605145903","pubTimestamp":1768919280,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"Johnson & Johnson's Janssen Biotech unit is the latest to sign up, agreeing a 'cross-modality, multi-target research collaboration' with Isomorphic that will combine its design engine with J&J's expertise in drug development.強生旗下的楊森生物技術部門是最新的簽約方，同意與Isomorphic達成「跨模式、多靶點研究合作」，將其設計引擎與強生在藥物開發方面的專業知識相結合。While those two projects focused mainly on small-molecule therapeutics, with J&J, Isomorphic is also working on large molecule and biologics design.雖然前兩個項目主要集中在小分子治療藥物上，但與強生合作時，Isomorphic 也在從事大分子和生物製劑的設計工作。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","SG9999002232.USD":"Allianz Global High Payout USD","LU0787776722.HKD":"AB SELECT US EQUITY PORTFOLIO \"A\" (HKD) ACC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","BK4559":"巴菲特持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","SG9999002224.SGD":"Allianz Global High Payout SGD","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","BK4550":"红杉资本持仓","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU2471134952.CNY":"INVESCO GLOBAL EQUITY INCOME ADVANTAGE \"A\" (CNYHDG) INC","IE00BDGV0183.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) INC","IE0034235303.USD":"PINEBRIDGE US RESEARCH ENHANCED CORE EQUITY \"A\" (USD) ACC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","JNJ":"强生","BK4534":"瑞士信贷持仓","LU2129689605.HKD":"FRANKLIN GLOBAL INCOME \"A\" (HKD) INC","BK4007":"制药","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU0345769128.USD":"NINETY ONE GSF GLOBAL EQUITY \"A\" (USD) ACC","LU2129689514.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) INC","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","LU2129689431.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) ACC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","LU0122379950.USD":"贝莱德世界健康科学A2","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","LU2430703178.SGD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (SGDHDG) INC","LU0058720904.USD":"联博国际健康护理基金A","BK4585":"ETF&股票定投概念","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0124676726.USD":"AB SICAV I - SUSTAINABLE US THEMATIC PORTFOLIO \"A\" (USD) ACC","BK4504":"桥水持仓","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus"},"translate_title":"Johnson & Johnson bets on Isomorphic for AI-powered drug hunt","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1.5},"content_text":"Alphabet-backed startup Isomorphic Labs has added another name to the roster of pharma companies tapping into its AI-based drug discovery engine.Alphabet支持的初創公司Isomorphic Labs已將另一家制藥公司加入到使用其基於人工智能的藥物發現引擎的名單中。Johnson & Johnson's Janssen Biotech unit is the latest to sign up, agreeing a 'cross-modality, multi-target research collaboration' with Isomorphic that will combine its design engine with J&J's expertise in drug development.強生旗下的楊森生物技術部門是最新的簽約方，同意與Isomorphic達成「跨模式、多靶點研究合作」，將其設計引擎與強生在藥物開發方面的專業知識相結合。Other companies that have partnered with the London, UK-based startup include與其他公司合作的倫敦（英國）初創公司包括Eli Lilly and Novartis禮來公司和諾華公司, which have together pledged almost $3 billion to projects powered by Isomorphic's platform.，這些項目共同承諾了近 30 億美元的資金，用於支持同構平台驅動的項目。While those two projects focused mainly on small-molecule therapeutics, with J&J, Isomorphic is also working on large molecule and biologics design.雖然前兩個項目主要集中在小分子治療藥物上，但與強生合作時，Isomorphic 也在從事大分子和生物製劑的設計工作。Under the terms of the J&J deal, Isomorphic will be responsible for根據J&J協議的條款，Isomorphic將負責in silico計算機模擬predictions and design, while the US group will conduct experimental assays and assume responsibility for advancing programmes through development. The financial terms and the therapeutic categories covered by the alliance have not been disclosed.預測和設計，而美國團隊將進行實驗分析並負責推進項目通過開發階段。聯盟所涵蓋的財務條款和治療類別尚未披露。'This collaboration is about more than speed; it is about unlocking uncharted frontiers in biology,' said Sarah Skerrat, Isomorphic's chief research officer.「這次合作不僅僅是關於速度；它還關乎於解鎖生物學中未曾探索的前沿領域，」Isomorphic首席研究官莎拉·斯凱拉特表示。'By accessing Isomorphic's planet-scale computing power and unified AI-driven drug design engine, the partnership will tackle targets that have historically been difficult to drug,' she added.「通過獲取Isomorphic的行星規模計算能力和統一的AI驅動藥物設計引擎，該合作將解決歷史上難以成藥的靶點問題，」她補充道。Last year, the UK company – which is led by DeepMind founder Sir Demis Hassabis – raised a massive去年，這家由DeepMind創始人戴密斯·哈薩比斯爵士領導的英國公司籌集了鉅額資金$600 million6億美元in its first external financing round, which was led by Thrive Capital, with participation from Google's GV venture capital unit as well as Alphabet.在其第一輪外部融資中，由Thrive Capital領投，谷歌的GV風險投資部門以及Alphabet參與。Isomorphic was set up in 2021 to develop DeepMind's同構體公司於 2021 年成立，旨在開發 DeepMind 的AlphaFold阿爾法摺疊engine that, in 2020, became the first to solve the tricky problem of predicting protein folding. Now in its third iteration, the model can predict the structure and relationships not only of proteins, but 'all of life's molecules,' according to the company.2020年，這一引擎成為首個解決蛋白質摺疊預測難題的引擎。據公司介紹，該模型目前已迭代至第三版，不僅能預測蛋白質的結構和關係，還可以預測「所有生命分子」的結構和關係。Max Jederberg, who recently transitioned from chief AI officer to president of Isomorphic, said in a LinkedIn post that the partnership 'reflects our belief that AI can truly transform human health, and I'm excited to see our teams join forces to move these breakthroughs forwards for patients.'最近從首席人工智能官轉型為Isomorphic總裁的馬克斯·耶德伯格在領英帖子中表示，此次合作「反映了我們對人工智能能夠真正改變人類健康的信念，我非常高興看到我們的團隊齊心協力，為患者推動這些突破性進展。」","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}